Anthony DiNatale, PhD

Anthony joined LifeSci Consulting in January 2023. He leverages his deep scientific and clinical expertise to complete projects spanning commercial opportunity assessments, indication prioritizations, corporate development, and competitive landscape evaluations across numerous therapeutic and technology areas with expertise in oncology, rare diseases, ophthalmology, and genome editors. Prior to joining LifeSci, he completed a Post-Doctoral Fellowship at the Janssen Pharmaceutical Companies of Johnson & Johnson, where he focused on the development of T-cell engagers. Anthony received a Ph.D. in Pharmacology and Physiology with his doctoral research focused on developing novel therapeutics for metastatic prostate cancer and breast cancer. He also completed pre-clinical medical school within the M.D./Ph.D. program at Drexel University College of Medicine. He received a B.S. with Honors in Biochemistry at SUNY Geneseo.